TABLE 2.
Summary statistics of treatment efficacy
| Sequence Group
|
Overall treatment effect Active vs. Inactive | ||||||||
|---|---|---|---|---|---|---|---|---|---|
| Active→Inactive N=7 |
Inactive→Active N=9 |
||||||||
| Active Inactive | Diffa | Meanb | Active | Inactive | Diffa | Meanb | |||
| FES-I | |||||||||
| Mean | 24.1 | 26.0 | −1.9 | 25.1 | 22.7 | 27.1 | −4.4 | 24.9 | −3.2 (p=0.059) |
| sd | 7.1 | 7.6 | 6.1 | 6.7 | 3.5 | 5.3 | 6.0 | 3.3 | |
| MiniBEST | |||||||||
| Mean | 25.0 | 24.1 | 0.9 | 24.6 | 22.3 | 20.2 | 2.1 | 21.3 | 1.5 (p=0.037) |
| sd | 2.3 | 2.1 | 1.7 | 2.0 | 4.5 | 3.7 | 3.1 | 3.9 | |
a
patient difference between active and inactive scores
b
patient mean of active and inactive scores